Standout Papers

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the ... 2012 2026 2016 2021 550
  1. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial (2012)
    Oliver A. Cornely, Derrick W. Crook et al. The Lancet Infectious Diseases

Immediate Impact

6 from Science/Nature 104 standout
Sub-graph 1 of 17

Citing Papers

Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update
2024 Standout
Mining human microbiomes reveals an untapped source of peptide antibiotics
2024 Standout
1 intermediate paper

Works of Karl Weiss being referenced

Biochemical markers for the diagnosis and monitoring of Wilson Disease
2019
Multicenter, Randomized Clinical Trial To Compare the Safety and Efficacy of LFF571 and Vancomycin for Clostridium difficile Infections
2014

Author Peers

Author Last Decade Papers Cites
Karl Weiss 1108 926 381 37 1.5k
R.H. George 951 646 262 43 1.6k
T.-W. Chang 1806 927 271 30 2.1k
H Elliott Larson 1356 741 184 31 1.8k
Hanna Pituch 1374 772 275 77 1.6k
Y Arabi 753 511 679 32 1.6k
Nadine M. Sullivan 870 542 191 25 1.5k
Denise Youngs 464 569 616 44 1.5k
V. Lalande 1520 1125 330 64 1.9k
Marlene Wullt 796 520 187 24 1.4k
Veli‐Jukka Anttila 1193 986 294 87 2.1k

All Works

Loading papers...

Rankless by CCL
2026